Bioplus Acquisition Corp Cl A (BIOS)
Bioplus Acquisition Corp Cl A (BIOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOS | DGX | ELAN | DVA | EHC |
| Company | Bioplus Acquisition Corp Cl A | Quest Diagnostics Inc | Elanco Animal Health Inc | Davita Healthcare Partners Inc | Encompass Health Corp |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
| Open | 10.80 | 136.12 | 16.82 | 136.02 | 85.20 |
| High | 10.80 | 136.94 | 16.97 | 137.65 | 85.84 |
| Low | 10.79 | 136.00 | 16.56 | 135.50 | 85.00 |
| Last | 10.80 | 136.94 | 16.95 | 137.37 | 85.47 |
| Change | -0.01 | +0.80 | +0.06 | +1.52 | +0.18 |
| % Change | -0.05% | +0.59% | +0.36% | +1.12% | +0.21% |
| Volume | 5,600 | 59,300 | 1,141,382 | 62,826 | 35,592 |
| 20-Day Average Volume | 10,870 | 1,015,353 | 4,934,491 | 816,963 | 685,090 |
| Previous Close | 10.80 | 136.14 | 16.89 | 135.85 | 85.29 |
| Industry | Unclassified | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.81 | 133.71 | 13.76 | 133.93 | 82.36 |
| 20-Day Raw Stochastic | 35.71% | 65.96% | 92.29% | 60.57% | 85.01% |
| 20-Day Relative Strength | 54.30% | 56.74% | 66.57% | 56.09% | 65.25% |
| Weighted Alpha | +7.20 | +5.71 | +83.34 | +54.57 | +44.00 |
| Today's Opinion | 80% Buy | 72% Buy | 56% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 80% Buy | 56% Buy | 48% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 24% Buy | 80% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.32% since 09/28/23 | +0.23% since 05/02/24 | +25.32% since 05/02/24 | -3.41% since 05/02/24 | +2.36% since 05/02/24 |
| Low | 10.78 on 10/04/23 | 135.26 on 05/03/24 | 13.22 on 05/07/24 | 131.27 on 05/03/24 | 82.83 on 05/03/24 |
| High | 10.84 on 09/29/23 | 138.11 on 05/06/24 | 17.23 on 05/08/24 | 145.04 on 05/03/24 | 86.60 on 05/07/24 |
| 1-Month | |||||
| %Chg | +0.14% since 09/06/23 | +2.95% since 04/09/24 | +10.54% since 04/09/24 | +2.47% since 04/09/24 | +4.20% since 04/09/24 |
| Low | 10.78 on 10/04/23 | 125.42 on 04/18/24 | 12.69 on 04/19/24 | 125.64 on 04/18/24 | 78.53 on 04/18/24 |
| High | 10.84 on 09/25/23 | 142.46 on 04/29/24 | 17.23 on 05/08/24 | 145.04 on 05/03/24 | 86.60 on 05/07/24 |
| 3-Month | |||||
| %Chg | +1.55% since 07/06/23 | +7.83% since 02/09/24 | +5.70% since 02/09/24 | +25.06% since 02/09/24 | +17.08% since 02/09/24 |
| Low | 10.63 on 07/19/23 | 123.30 on 02/21/24 | 12.69 on 04/19/24 | 108.76 on 02/12/24 | 72.38 on 02/12/24 |
| High | 11.68 on 08/18/23 | 142.46 on 04/29/24 | 17.23 on 05/08/24 | 145.04 on 05/03/24 | 86.60 on 05/07/24 |
| 6-Month | |||||
| %Chg | +3.25% since 04/05/23 | +3.81% since 11/09/23 | +64.52% since 11/09/23 | +62.96% since 11/09/23 | +34.30% since 11/09/23 |
| Low | 10.44 on 04/18/23 | 123.04 on 02/01/24 | 10.28 on 11/10/23 | 82.79 on 11/10/23 | 62.58 on 11/10/23 |
| High | 11.68 on 08/18/23 | 143.63 on 01/02/24 | 17.23 on 05/08/24 | 145.04 on 05/03/24 | 86.60 on 05/07/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 209,067 | 15,124,065 | 8,345,298 | 11,914,044 | 8,587,423 |
| Shares Outstanding, K | 19,367 | 111,092 | 494,097 | 87,700 | 100,685 |
| Annual Sales | 708,900,000 | 9,252,000,000 | 4,417,000,000 | 12,140,150,000 | 4,801,200,000 |
| Annual Net Income | -51,690,000 | 854,000,000 | -1,231,000,000 | 691,540,000 | 352,000,000 |
| Last Quarter Sales | 0 | 2,366,000,000 | 1,035,000,000 | 3,070,560,000 | 1,316,000,000 |
| Last Quarter Net Income | 1,240,548 | 194,000,000 | -141,000,000 | 239,650,000 | 112,500,000 |
| 60-Month Beta | 0.01 | 0.88 | 1.34 | 1.04 | 0.92 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.04 on 04/23/24 | 0.34 on 05/08/24 | 2.38 on 05/02/24 | 1.12 on 04/24/24 |
| Latest Earnings Date | 03/20/20 | 04/23/24 | 05/08/24 | 05/02/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.710 on 01/16/24 | N/A | N/A | 0.150 on 03/28/24 |
| Next Ex-Dividends Date | N/A | 01/16/24 | N/A | N/A | 06/28/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.72 | 15.19 | 15.00 | 22.13 |